Joseph E. McClellan
Directeur Technique/Scientifique/R&D chez ALVOTECH
Fortune : - $ au 30/06/2024
Profil
Joseph E.
McClellan is currently the Chief Scientific Officer at Alvotech hf and Alvotech.
Previously, he worked at Pfizer Inc. as the Global Head-Biosimilars Development & Medicine.
McClellan completed his undergraduate degree at the College of the Holy Cross (Massachusetts), his doctorate at the University of Florida, and his MBA at Northeastern University (China).
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ALVOTECH
-.--% | 15/02/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Joseph E. McClellan
Sociétés | Poste | Début |
---|---|---|
ALVOTECH | Directeur Technique/Scientifique/R&D | 01/10/2019 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Directeur Technique/Scientifique/R&D | 01/10/2019 |
Anciens postes connus de Joseph E. McClellan
Sociétés | Poste | Fin |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - |
Formation de Joseph E. McClellan
University of Florida | Doctorate Degree |
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Northeastern University (China) | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALVOTECH | Health Technology |
PFIZER, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |